FDA DIRECT-TO-CONSUMER BROADCAST GUIDANCE TO BE EVALUATED AFTER TWO YEARS; "ADEQUATE PROVISION" OF LABELING POSSIBLE THROUGH FOUR-PART APPROACH

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".